Ely Gold Royalties (CVE:ELY) Reaches New 1-Year High at $1.27

Share on StockTwits

Shares of Ely Gold Royalties Inc (CVE:ELY) hit a new 52-week high during trading on Friday . The company traded as high as C$1.27 and last traded at C$1.24, with a volume of 881406 shares traded. The stock had previously closed at C$1.19.

The company has a current ratio of 2.99, a quick ratio of 2.94 and a debt-to-equity ratio of 12.08. The stock has a market capitalization of $103.42 million and a P/E ratio of -79.38. The company has a fifty day simple moving average of C$0.83 and a two-hundred day simple moving average of C$0.62.

In other news, Director William Morris Sheriff sold 32,000 shares of Ely Gold Royalties stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of C$0.81, for a total transaction of C$25,920.00. Following the completion of the sale, the director now owns 258,000 shares in the company, valued at approximately C$208,980.

About Ely Gold Royalties (CVE:ELY)

Ely Gold Royalties Inc, an exploration stage natural resource company, engages in the evaluation, acquisition, exploration, and development of natural resource projects in North America. It primarily explores for gold and precious metal deposits. Ely Gold Royalties Inc has a portfolio of 31 deeded royalties and 19 optioned properties.

See Also: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for Ely Gold Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ely Gold Royalties and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Obsidian Energy   Shares Down 11.1%
Obsidian Energy Shares Down 11.1%
Genesis Metals  Stock Price Down 10.4%
Genesis Metals Stock Price Down 10.4%
Benton Resources  Stock Price Down 10%
Benton Resources Stock Price Down 10%
Adaptimmune Therapeutics  Sets New 52-Week High at $6.04
Adaptimmune Therapeutics Sets New 52-Week High at $6.04
Datadog  Reaches New 12-Month High at $73.78
Datadog Reaches New 12-Month High at $73.78
Centerra Gold  Hits New 1-Year High on Analyst Upgrade
Centerra Gold Hits New 1-Year High on Analyst Upgrade


© 2006-2020 Ticker Report